Company News
https://chimebiologics.com/wp-content/uploads/2020/03/3-line-long-gfx-orange.png
26
1055
Lumy Chen
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
Lumy Chen2021-11-29 11:51:362021-11-29 12:02:43鼎康生物PAI生产正式启动，拉开GMP商业化生产序幕
https://chimebiologics.com/wp-content/uploads/2020/03/3-line-long-gfx-orange.png
26
1055
Lumy Chen
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
Lumy Chen2021-10-15 10:05:202021-10-15 10:05:20Cytiva与鼎康生物宣布开展GMP-2扩建项目合作
https://chimebiologics.com/wp-content/uploads/2020/03/3-line-long-gfx-orange.png
26
1055
Lumy Chen
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
Lumy Chen2021-10-14 16:54:262021-10-14 17:32:55鼎康生物与斯微生物达成战略合作协议
https://chimebiologics.com/wp-content/uploads/2020/03/3-line-long-gfx-orange.png
26
1055
Lumy Chen
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
Lumy Chen2021-09-28 16:23:292021-09-28 16:23:29
https://chimebiologics.com/wp-content/uploads/2020/03/3-line-long-gfx-orange.png
26
1055
Lumy Chen
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
Lumy Chen2021-09-24 09:05:152021-09-24 09:05:15
https://chimebiologics.com/wp-content/uploads/2020/03/3-line-long-gfx-orange.png
26
1055
Lumy Chen
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
Lumy Chen2021-08-04 22:27:062021-08-05 09:49:16Chime Biologics announced the expansion of GMP manufacturing capacity with construction of a second GMP facility (GMP-2)
https://chimebiologics.com/wp-content/uploads/2020/03/3-line-long-gfx-orange.png
26
1055
Zhou, Victor
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
Zhou, Victor2021-07-07 10:14:542021-07-07 10:31:54Chime Biologics and Great Bay Bio enter into Strategic Alliance
https://chimebiologics.com/wp-content/uploads/2020/03/3-line-long-gfx-orange.png
26
1055
Lumy Chen
https://chimebiologics.com/wp-content/uploads/2020/03/logo-ch-en-257.png
Lumy Chen2021-05-18 09:32:162021-07-14 15:00:04Humanigen and Chime Biologics Enter Into Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab